HIV clinicians in Spain underestimate their patients’ HIV-related symptoms
Increasing and changing pattern of treatment switches among people with HIV
Dolutegravir may increase blood clotting affecting stroke and heart attack risk, early findings warn
Integrase inhibitors more likely to be linked to depression and suicidality than other HIV drugs
No link between weight gain on integrase inhibitors and diabetes
Can testing for drug-gene interactions improve treatment success in people with HIV?
Daily PrEP is safe for the kidneys, although on-demand PrEP has slightly less impact
CD4 and white blood cell declines caused by islatravir are dose-related and reversible, but rule out using it for prevention
Vitamin D and calcium supplements suggested to avert bone disease in people taking tenofovir-based ART and PrEP
